Somnoware, a Santa Clara, CA-based provider of digital health technology, closed $3.5M in funding.
The company intends to use the funds to further accelerate market expansion and enable development of key artificial intelligence (AI) technologies.
Led by Subath Kamalasan, CEO, Somnoware provides an artificial intelligence (AI) driven chronic respiratory healthcare platform currently used by sleep physicians and pulmonologists.
It is available in two versions — Somnoware for Physicians and Somnoware for Testing Facilities. Physicians get instant access to diagnostic test data, e-signature capability, one-click DME ordering, CPAP compliance data, and the ability to conduct end-to-end patient care management.
Sleep and pulmonary test centers can automate their complete workflow including scheduling at multiple centers, inventory management, automated reporting, therapy ordering, and AASM accreditation.
The customer base includes health systems, accountable care organizations, independent test labs, and service companies.